Have a personal or library account? Click to login
The retrospective molecular analysis of large or giant congenital melanocytic nevi in a group of Polish children Cover

The retrospective molecular analysis of large or giant congenital melanocytic nevi in a group of Polish children

Open Access
|Oct 2021

References

  1. Nikfarjam J, Chambers E. Congenital melanocytic nevi and the risk of malignant melanoma: establishing a guideline for primary-care physicians. Einstein J Biol Med. 2011;27(2):59-66. doi: 10.23861/EJBM20112745.
  2. Shah J, Feintisch AM, Granick MS. Congenital melanocytic nevi. Eplasty. 2016 Jan 28;16:ic4.
  3. del Carmen Boente M. Congenital melanocytic nevi. p. 249-60. In: Pediatric skin of color. Eds. Silverberg NB, Durán-McKinster C, Tay Y-K. New York: Springer-Verlag, 2015; XV, 473 p. ISBN 9781-4614-6653-6 (hardcover). ISBN 978-1-4614-6654-3 (eBook). doi: 10.1007/978-1-4614-6654-3.
  4. Price HN. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr. 2016;28(4):476-82. doi: 10.1097/MOP.0000000000000384.
  5. Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol. 2013;133(9):2229-36. doi: 10.1038/jid.2013.70.
  6. Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441-51. doi: 10.1016/j.jaad.2012.05.043.
  7. Polubothu S, McGuire N, Al-Olabi L, Baird W, Bulstrode N, Chalker J, et al. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi. Br J Dermatol. 2020;182(2):434-43. doi: 10.1111/bjd.18106.
  8. Dessars B, De Raeve LE, Morandini R, Lefort A, El Housni H, Ghanem GE, et al. Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. J Invest Dermatol. 2009;129(1):139-47. doi: 10.1038/jid.2008.203.
  9. Bekiesińska-Figatowska M, Szczygielski O, Boczar M, Mądzik J, Klepacka T, Michalak E, et al. Neurocutaneous melanosis in children with giant congenital melanocytic nevi. Clin Imaging. 2014;38(2):79-84. doi: 10.1016/j.clinimag.2013.10.001.
  10. Sawicka E, Szczygielski O, Żak K, Pęczkowski P, Michalak E, Bekiesińska-Figatowska M. Giant congenital melanocytic nevi: selected aspects of diagnostics and treatment. Med Sci Monit. 2015 Jan 11;21:123-32. doi: 10.12659/MSM.891279.
  11. Roh MR, Eliades P, Gupta S, Tsao H. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. 2015;28(6):661-72. doi: 10.1111/pcmr.12412.
  12. Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006;126(9):2111-8. doi: 10.1038/sj.jid.5700366.
  13. Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol. 2014;134(4):1067-74. doi: 10.1038/jid.2013.429.
  14. Stark MS. Large-giant congenital melanocytic nevi: moving beyond NRAS mutations. J Invest Dermatol. 2019;139(4):756-9. doi: 10.1016/j.jid.2018.10.003.
  15. Alqathama A. BRAF in malignant melanoma progression and metastasis: potentials and challenges. Am J Cancer Res. 2020;10(4):1103-14.
  16. Frech M, Darden TA, Pedersen LG, Foley CK, Charifson PS, Anderson MW, Wittinghofer A. Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical study. Biochemistry. 1994;33(11):3237-44. doi: 10.1021/bi00177a014.
  17. Hélias-Rodzewicz Z, Funck-Brentano E, Terrones N, Beauchet A, Zimmermann U, Marin C, et al. Variation of mutant allele frequency in NRAS Q61 mutated melanomas. BMC Dermatol. 2017;17(1):9. doi: 10.1186/s12895-017-0061-x.
  18. Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbour NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127(1):179-82. doi: 10.1038/sj.jid.5700490.
  19. Martins da Silva V, Martinez-Barrios E, Tell-Martí G, Dabad M, Carrera C, Aguilera P, et al. Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations. J Invest Dermatol. 2019;139(4):900-8. doi: 10.1016/j.jid. 2018.07.045.
  20. Pedersen M, Küsters-Vandevelde HVN, Viros A, Groenen PJTA, Sanchez-Laorden B, Gilhuis JH, et al. Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. Cancer Discov. 2013 ;3(4) :458-69. doi : 10.1158/2159-8290.CD-12-0464.
  21. Burd CE, Liu W, Huynh MV, Waqas MA, Gillahan JE, Clark KS, et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov. 2014;4(12):1418-29. doi: 10.1158/2159-8290.CD-14-0729.
  22. AACR Project GENIE Consortium. AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818-31. doi: 10.1158/2159-8290.CD-17-0151.
DOI: https://doi.org/10.34763/jmotherandchild.20212501.d-21-00007 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Language: English
Page range: 19 - 24
Submitted on: Mar 7, 2021
|
Accepted on: Apr 22, 2021
|
Published on: Oct 11, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Katarzyna Wertheim-Tysarowska, Orest Szczygielski, Katarzyna Seliga, Andrzej Tysarowski, Jerzy Bal, Elżbieta Michalak, Agnieszka Magdalena Rygiel, Ewa Sawicka, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.